You have 9 free searches left this month | for more free features.

Newly diagnosed and previously untreated acute myeloid leukemia (AML)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myelogenous Leukemia (AML) Due to Therapy, Acute Myeloid Leukemia With Myelodysplasia-Related Changes Trial in La Jolla,

Recruiting
  • Acute Myelogenous Leukemia (AML) Due to Therapy
  • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
  • Orange, California
  • +2 more
Nov 30, 2022

Acute Myeloid Leukemia Trial in United States (Tamibarotene, Venetoclax, Azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +7 more
Mar 27, 2022

Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    Sep 22, 2023

    Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • Suzhou, Jiangsu, China
      Qiu Huiying
    Mar 28, 2023

    Acute Myeloid Leukemia Trial in Kunming (Venetoclax in combination with azacitidine and CAG)

    Recruiting
    • Acute Myeloid Leukemia
    • Venetoclax in combination with azacitidine and CAG
    • Kunming, Yunnan, China
      920th Hospital of Joint Logistics Support Force of People's Libe
    Dec 20, 2022

    Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Vienna, Austria
    • +3 more
    Jun 8, 2023

    Acute Myeloid Leukemia Trial in Aurora (Azacitidine and Venetoclax)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Azacitidine and Venetoclax
    • Aurora, Colorado
      University of Colorado Denver
    Aug 1, 2022

    Acute Myeloid Leukemia, Venetoclax Trial in Kunming (combination of venetoclax and HAA regimen)

    Recruiting
    • Acute Myeloid Leukemia
    • Venetoclax
    • combination of venetoclax and HAA regimen
    • Kunming, Yunnan, China
      The Second Affiliated Hospital of Kunming Medical University.
    May 29, 2023

    Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)

    Recruiting
    • Acute Myeloid Leukemia
    • Azacitidine Combined With Venetoclax and ATRA group
    • Suzhou, China
      the First Affiliated Hospital of Soochow University
    Dec 8, 2022

    Acute Myeloid Leukemia Trial in Baltimore, New York, Chapel Hill (Alvocidib, Cytarabine, Daunorubicin)

    Completed
    • Acute Myeloid Leukemia
    • Baltimore, Maryland
    • +2 more
    Apr 4, 2022

    Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • AML Stage, Adult
    • Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
    • Xiamen, Fujian, China
      Bing Xu
    Oct 29, 2022

    Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028 Dose Escalation)

    Recruiting
    • Newly Diagnosed Acute Myeloid Leukemia (AML)
    • SKLB1028 Dose Escalation
    • Chengdu, China
      West China Hospital of Sichuan University
    Jun 30, 2022

    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

    Completed
    • Adult Acute Megakaryoblastic Leukemia (M7)
    • +13 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Feb 2, 2023

    UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Wuhan (Basic

    Recruiting
    • UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
    • Basic chemotherapy + UCB transplantation
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Oct 9, 2022

    Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Mitoxantrone hydrochloride liposome injection
    • +3 more
    • (no location specified)
    May 29, 2023

    Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Mitoxantrone hydrochloride liposome injection
    • +3 more
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jul 1, 2023

    Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

    Not yet recruiting
    • Acute Myeloid Leukemia in Children
    • Standard Intervention
    • Investigational Intervention
    • (no location specified)
    Aug 8, 2023

    Acute Myeloid Leukemia (AML) Trial in Tianjin (Quizartinib)

    Completed
    • Acute Myeloid Leukemia (AML)
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    Jul 27, 2022

    Acute Myeloid Leukemia, MDS Trial in Ulm (drug, combination product, other)

    Recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Berlin, Germany
    • +9 more
    Jan 13, 2023

    Acute Myeloid Leukemia Trial in Lanzhou (Venetoclax, Azacitidine, Cladribine)

    Recruiting
    • Acute Myeloid Leukemia
    • Lanzhou, Gansu, China
      Long Zhao
    Apr 24, 2022

    Acute Myeloid Leukemia Trial (Sulfasalazine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Oct 11, 2022

    Acute Myeloid Leukemia Trial in Tianjin (Different induction chemo regimens)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Different induction chemotherapy regimens
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Sep 27, 2023

    Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)

    Recruiting
    • Acute Myeloid Leukemia
    • Magrolimab
    • +3 more
    • Little Rock, Arkansas
    • +82 more
    Jan 17, 2023

    Acute Myeloid Leukemia Trial in Chicago (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Chicago, Illinois
      Northwestern University
    Feb 16, 2023